Talaris Therapeutics (NASDAQ:TALS – Get Rating) and Rubius Therapeutics (NASDAQ:RUBY – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership. Valuation and Earnings This table compares Talaris Therapeutics and […]